Efficacy of Infigratinib on Achondroplasia @checkrare
Efficacy of Infigratinib on Achondroplasia  @checkrare
Uploaded October 2026 | Updated November 2026, 17 hours ago
Daniela Rogoff, MD, PhD, Chief Medical Officer, Skeletal Dysplasia of BridgeBio, discusses the efficacy of infigratinib to treat persons with achondroplasia.

To view the full interview, visit checkrare.com/efficacy-of-infigratinib-on-achondroplasia
Efficacy of Infigratinib on AchondroplasiaMolecular Changes Associated With Teprotumumab Treatment in Thyroid Eye DiseaseInvestigating Results From the MAVORIC Trial in Patients With CTCLMiv-cel Shows Durable Results in Stiff Person Syndrome and Myasthenia GravisUCB Study Highlights the Burden of Ocular Myasthenia GravisGambling on Clinical TrialsMolecular Changes Associated With Teprotumumab Treatment in Thyroid Eye DiseaseMiv-cel Shows Durable Results in Stiff Person Syndrome and Myasthenia GravisNarcolepsy Awareness MonthFirst-Line Therapy Approved for Rare Lung Cancer  Safety and Efficacy of Kygevvi in Thymidine Kinase 2 DeficiencyPredicting Treatment Response Outcomes With Proteomic and Machine Learning Analyses in MG
CheckRare |

Efficacy of Infigratinib on Achondroplasia

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER